SABCS 2022 Conference Coverage
Playback speed
10 seconds
SABCS 2022 TROPiCS-02 Phase 3 Study of Patients With HR+/HER2- mBC: Sacituzumab Govitecan vs. Treatment of Physician’s Choice - Efficacy by Trop-2 Expression
By
SABCS 2022 Conference Coverage
FEATURING
Hope Rugo
By
SABCS 2022 Conference Coverage
FEATURING
Hope Rugo
162 views
December 23, 2022
Login to view comments.
Click here to Login
Videos